{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T04:17:13Z","timestamp":1777004233133,"version":"3.51.4"},"reference-count":36,"publisher":"BMJ","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["British Journal of Ophthalmology"],"published-print":{"date-parts":[[1991,11,1]]},"DOI":"10.1136\/bjo.75.11.675","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T21:53:19Z","timestamp":1190152399000},"page":"675-679","source":"Crossref","is-referenced-by-count":22,"title":["Ofloxacin compared with chloramphenicol in the management of external ocular infection."],"prefix":"10.1136","volume":"75","author":[{"given":"A. J.","family":"Bron","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Leber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. N.","family":"Rizk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Baig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. R.","family":"Elkington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. R.","family":"Kirkby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Neoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Harden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Leong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","first-page":"576","article-title":"Multiply resistant class A pathogen, is considered insensitive to chloramphenicol treatment.25 The MIC90 for Pneumococcus causing meningitis: its epidemiology within a 3 Abdraaym-csarSeMc, entDree.gLnaannceTt]1,98V1i; nici:ig7u7e1r-r3a. V. Marrow aplasia ofloxacin is 4 [tg\/ml compared with 128 [tg\/ml for chloramphenicol against P. aeruginosa.\" The following topical application of chloramphenicol eye ointment","volume":"140","author":"Radetsky, M.S.; Istre, G.R.; Johansen, T.L.","year":"1980","unstructured":"Radetsky MS, Istre GR, Johansen TL, et al. Multiply resistant class A pathogen, is considered insensitive to chloramphenicol treatment.25 The MIC90 for Pneumococcus causing meningitis: its epidemiology within a 3 Abdraaym-csarSeMc,entDree.gLnaannceTt]1,98V1i;nici:ig7u7e1r-r3a. V. Marrow aplasia ofloxacin is 4 [tg\/ml compared with 128 [tg\/ml for chloramphenicol against P. aeruginosa.\" The following topical application of chloramphenicol eye ointment. Arch Intern Med 1980; 140: 576-7.","journal-title":"Arch Intern Med"},{"key":"ref_2","first-page":"227","article-title":"The potential use of quinolones in Chloramphenicol resistance occurs in many pathogenic species, including H. influenzae and future ocular antimicrobial therapy","volume":"106","author":"Borrmann, L.R.; Leopold, I.H.","year":"1988","unstructured":"Borrmann LR, Leopold IH. The potential use of quinolones in Chloramphenicol resistance occurs in many pathogenic species, including H. influenzae and future ocular antimicrobial therapy. AmJ7 Ophthalmol 1988; 106: 227-9."},{"issue":"4","key":"ref_3","first-page":"226","article-title":"High frequencies of resistance, ranging from 30% to 58% of clinical isolates, bacterial activity ofofloxacin and its mode of action","volume":"14","author":"Sato, K.; Inoue, Y.; Fujii, T.; Aoyama, H.; pneumoniae, Mitsuhashi S.Anti- S.","year":"1986","unstructured":"Sato K, Inoue Y, Fujii T, Aoyama H, Mitsuhashi S. Anti- S. pneumoniae. High frequencies of resistance, ranging from 30% to 58% of clinical isolates, bacterial activity ofofloxacin and its mode of action. Infection 1986; 14 (suppl 4): S226-30.","journal-title":"Infection"},{"key":"ref_4","first-page":"55","article-title":"The in-vitro activities of because plasmid-borne factors exist, and conjugative transfer of the plasmid occurs.29-3' In contrast, ofloxacin-resistant strains seldom arise, and the development of plasmid-borne enoxacin and ofloxacin compared with that of ciprofloxacin","volume":"15","author":"King, A.; Shannon, K.; Phillips, I.","year":"1985","unstructured":"King A, Shannon K, Phillips I. The in-vitro activities of because plasmid-borne factors exist, and conjugative transfer of the plasmid occurs.29-3' In contrast, ofloxacin-resistant strains seldom arise, and the development of plasmid-borne enoxacin and ofloxacin compared with that of ciprofloxacin. JAntimicrob Chemother 1985; 15: 55 1-8.","journal-title":"JAntimicrob Chemother"},{"key":"ref_5","first-page":"213","article-title":"Susceptibility in vitro of gram-positive aerobe and anaerobe bacteria to ofloxacin","volume":"13","author":"Debbia, E.; Mannelli, S.; Gianrossi, G.; Schito, G.C.","year":"1987","unstructured":"Debbia E, Mannelli S, Gianrossi G, Schito GC. Susceptibility in vitro of gram-positive aerobe and anaerobe bacteria to ofloxacin. DrugsExpClinRes 1987; 13: 213-7.","journal-title":"DrugsExpClinRes"},{"key":"ref_6","first-page":"17","article-title":"The quinolones: mode ofaction and mechanism of resistance","volume":"7","author":"Kayser, F.H.","year":"1985","unstructured":"Kayser FH. The quinolones: mode ofaction and mechanism of resistance. Res Clin Forums 1985; 7: 17-24.","journal-title":"Res Clin Forums"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/jac\/16.4.475","article-title":"Antibacterial activity of ofloxacin and other 4-quinolone derivatives: in-vitro and in-vivo comparison","volume":"16","author":"Chantot, J.F.; Bryskier, A.","year":"1985","unstructured":"Chantot JF, Bryskier A. Antibacterial activity of ofloxacin and other 4-quinolone derivatives: in-vitro and in-vivo comparison. J Antimicrob Chemother 1985; 16: 475-84.","journal-title":"J Antimicrob Chemother"},{"key":"ref_8","first-page":"1115","article-title":"Effect of ofloxacin ophthalmic solution in the treatment of external bacterial phenicol can cause rare, but serious, blood dyscrasias, and fatal aplastic anaemia occurs in infections of the eye","volume":"37","author":"true","year":"1986","unstructured":"Mitsui Y, Sakuragi S, Tamura 0, et al. Effect of ofloxacin ophthalmic solution in the treatment of external bacterial phenicol can cause rare, but serious, blood dyscrasias, and fatal aplastic anaemia occurs in infections of the eye. Folia Ophthalmol Jpn 1986; 37: 1115-40.","journal-title":"Folia Ophthalmol Jpn"},{"key":"ref_9","article-title":"Macrolide and related antibiotics","volume-title":"about 1 in 40000 courses of systemic chloramphenicol therapy.3536 Topical ocular use of Okumoto MA, eds. Antimicrobial agents in ophthalmology","author":"Newman, P.","unstructured":"Newman P. Macrolide and related antibiotics. In: Smolin G, about 1 in 40000 courses of systemic chloramphenicol therapy.3536 Topical ocular use of Okumoto MA, eds. Antimicrobial agents in ophthalmology. New York: Masson, 1981: chapter 10."},{"key":"ref_10","first-page":"234","article-title":"Comparative enzymology of chloramphenicol chloramphenicol has also resulted in blood dyscrasias and deaths from aplastic anaemia, an idiosyncratic reaction that is independent of dose.3-1 37 resistance","volume":"182","author":"Shaw, W.V.","year":"1971","unstructured":"Shaw WV. Comparative enzymology of chloramphenicol chloramphenicol has also resulted in blood dyscrasias and deaths from aplastic anaemia, an idiosyncratic reaction that is independent of dose.3-1 37 resistance. Ann New York Acad Sci 1971; 182: 234-42.","journal-title":"Ann New York Acad Sci"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1128\/AAC.16.1.13","article-title":"Bactericidal and bacteriostatic action of chloramphenicol against meningeal pathogens","volume":"16","author":"Rahal, J.J.; SimberloffMS","year":"1979","unstructured":"Rahal JJ, SimberloffMS. Bactericidal and bacteriostatic action of chloramphenicol against meningeal pathogens. Antimicrob Agents Chemother 1979; 16: 13-8.","journal-title":"Antimicrob Agents Chemother"},{"key":"ref_12","first-page":"751","article-title":"Quantitative ocular bacteriology: a method for the enumeration and identification of bacteria Adverse reactions to systemic ofloxacin occur at low rates of 2% to 7% of treated patients.38 Clinical studies of 15962 patients yielded about four adverse reactions per 100 patients who were from the skin-lash margin and conjunctiva","volume":"20","author":"Cagle, G.D.; Abshire, R.L.","year":"1981","unstructured":"Cagle GD, Abshire RL. Quantitative ocular bacteriology: a method for the enumeration and identification of bacteria Adverse reactions to systemic ofloxacin occur at low rates of 2% to 7% of treated patients.38 Clinical studies of 15962 patients yielded about four adverse reactions per 100 patients who were from the skin-lash margin and conjunctiva. Invest Ophthalmol VisSci 1981; 20: 751-7.","journal-title":"Invest Ophthalmol VisSci"},{"key":"ref_13","first-page":"523","article-title":"Topical tobramycin and gentamicin sulfate in the treatment of ocular infections: multicenter study","volume":"1","author":"Cagle, G.D.; Davis, S.; Rosenthal, A.; Smith, J.","year":"1982","unstructured":"Cagle GD, Davis S,Rosenthal A, Smith J. Topical tobramycin and gentamicin sulfate in the treatment of ocular infections: multicenter study. Curr Eye Res 1982; 1: 523-34.","journal-title":"Curr Eye Res"},{"key":"ref_14","first-page":"237","article-title":"Average partial associaadministered an oral form of ofloxacin; such reactions were typically mild gastrointestinal tion on three-way contingency tables: a review and discussion of alternative tests","volume":"46","author":"Landis, R.J.; Heyman, E.R.; Koch, G.G.","year":"1978","unstructured":"Landis RJ, Heyman ER, Koch GG. Average partial associaadministered an oral form of ofloxacin; such reactions were typically mild gastrointestinal tion on three-way contingency tables: a review and discussion of alternative tests. IntStatist Rev 1978; 46: 237-54.","journal-title":"IntStatist Rev"},{"key":"ref_15","article-title":"complaints or minor nervous symptoms.39A low frequency, 0-5% (38\/7566), of adverse reactions Mitsuhashi S. In vitro and in vivo activity of DL-8280, a new oxazine derivative. Antimicrob Agents Chemother 1982; 22: 548-53. to an ophthalmic ofloxacin preparation was found in a post-marketing study completed in 1989 by Santen","author":"Sato, K.; Matsuura, Y.; Inoue, M.; Une, T.; Osada, Y.; Ogawa, H.","unstructured":"Sato K, Matsuura Y, Inoue M, Une T, Osada Y, Ogawa H, complaints or minor nervous symptoms.39A low frequency, 0-5% (38\/7566), of adverse reactions Mitsuhashi S. In vitro and in vivo activity of DL-8280, a new oxazine derivative. Antimicrob Agents Chemother 1982; 22: 548-53. to an ophthalmic ofloxacin preparation was found in a post-marketing study completed in 1989 by Santen Corp., Japan (communicated to Allergan Inc.)."},{"key":"ref_16","first-page":"193","article-title":"Anti-infective drugs","volume-title":"Clinical ocular pharmacology","author":"Chang, F.W.","year":"1984","unstructured":"Chang FW. Anti-infective drugs. In: Bartlett JD, JaanusSD, eds. Clinical ocular pharmacology. Boston: Butterworths, 1984: 193-220."},{"key":"ref_17","first-page":"295","article-title":"Chloramphenicol: new perspectives on an old drug. Drug Intellig Clin","volume":"16","author":"Powell, D.A.; Nahata, M.C.","year":"1982","unstructured":"Powell DA, Nahata MC. Chloramphenicol: new perspectives on an old drug. Drug Intellig Clin Pharm 1982; 16: 295-300.","journal-title":"Pharm"},{"key":"ref_18","first-page":"191","article-title":"Acute bacterial infections of the eye: their Ofloxacin possesses outstanding potency against a variety of pathogens, and is active against strains resistant to chloramphenicol and aetiology and treatment","volume":"67","author":"Mahajan, V.M.","year":"1983","unstructured":"Mahajan VM. Acute bacterial infections of the eye: their Ofloxacin possesses outstanding potency against a variety of pathogens, and is active against strains resistant to chloramphenicol and aetiology and treatment. Brj Ophthalmol 1983; 67: 191-4.","journal-title":"Brj Ophthalmol"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/jac\/21.5.581","article-title":"Susceptibility of Hong Kong isolates of methicillin-resistant Staphylococcus aureus to antimicrobial agents","volume":"21","author":"French, G.L.; Ling, J.; Ling, T.; Hui, Y.W.","year":"1988","unstructured":"French GL, Ling J, Ling T, Hui YW. Susceptibility of Hong Kong isolates of methicillin-resistant Staphylococcus aureus to antimicrobial agents. J Antimicrob Chemother 1988; 21: 581-8.","journal-title":"J Antimicrob Chemother"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1755-3768.1987.tb06989.x","article-title":"Fucithalmic in acute conjunctivitis. Open, randomized comparison of fusidic acid, chloramphenicol and framycetin eye drops","volume":"65","author":"Dirdal, M.","year":"1987","unstructured":"Dirdal M. Fucithalmic in acute conjunctivitis. Open, randomized comparison of fusidic acid, chloramphenicol and framycetin eye drops. Acta Ophthalmol (KGh) 1987; 65: 129-33.","journal-title":"Acta Ophthalmol (KGh)"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1128\/AAC.18.4.610","article-title":"Characterization of chloramphenicol resistant Haemophilus influenza","volume":"18","author":"Roberts, M.C.; Swensen, C.; Owens, L.; Smith, A.L.","year":"1980","unstructured":"Roberts MC, Swensen C, Owens L, Smith AL. Characterization of chloramphenicol resistant Haemophilus influenza. Antimicrob Agents Chemother 1980; 18: 610-5.","journal-title":"Antimicrob Agents Chemother"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0147-619X(86)90057-0","article-title":"Dispersal of a plasmid-borne chloramphenicol resistance gene in streptococcal and enterococcal plasmids","volume":"16","author":"Pepper, K.; Le Bouguenec, C.; de Cespedes, G.; Horaud, T.","year":"1986","unstructured":"Pepper K, Le Bouguenec C, de Cespedes G, Horaud T. Dispersal of a plasmid-borne chloramphenicol resistance gene in streptococcal and enterococcal plasmids. Plasmid 1986; 16: 195-203.","journal-title":"Plasmid"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1128\/AAC.11.3.383","article-title":"Plasmid-mediated chloramphenicol resistance in Haemophilus influenza","volume":"11","author":"B, Van Klingeren; J, Van Embden; M, Dessens-Kroon","year":"1977","unstructured":"Van Klingeren B, Van Embden J, Dessens-Kroon M. Plasmid-mediated chloramphenicol resistance in Haemophilus influenza. Antimicrob Agents Chemother 1977; 11: 383-7.","journal-title":"Antimicrob Agents Chemother"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1128\/AAC.32.8.1285","article-title":"Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin","volume":"32","author":"Kresken, M.; Wiedemann, B.","year":"1988","unstructured":"Kresken M, Wiedemann B. Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin. Antimicrob Agents Chemother 1988; 32: 1285-8.","journal-title":"Antimicrob Agents Chemother"},{"key":"ref_25","first-page":"156","article-title":"Mode of action, and in vitro and in vivo activities of the fluoroquinolones","volume":"28","author":"Fernandes, P.B.","year":"1988","unstructured":"Fernandes PB. Mode of action, and in vitro and in vivo activities of the fluoroquinolones. I Clin Pharmnacol 1988; 28: 156-68.","journal-title":"I Clin Pharmnacol"},{"issue":"1","key":"ref_26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-198700341-00002","article-title":"Development of resistance to ofloxacin","volume":"34","author":"Crumplin, G.C.; Odell, M.","year":"1987","unstructured":"Crumplin GC, Odell M. Development of resistance to ofloxacin. Drugs 1987; 34 (suppl 1): 1-8.","journal-title":"Drugs"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1001\/jama.1982.03320430023016","article-title":"Fatal aplastic anemia","volume":"247","author":"Fraunfelder, F.T.; Bagby, G.C.","year":"1982","unstructured":"Fraunfelder FT, Bagby GC. Fatal aplastic anemia. JAMA 1982; 247: 2499.","journal-title":"JAMA"},{"issue":"208","key":"ref_28","first-page":"2045","article-title":"Statewide study of chloramphenicol therapy and fatal aplastic anemia","volume":"1969","author":"Wallerstein, R.O.; Condit, P.K.; Kasper, G.K.","unstructured":"Wallerstein RO, Condit PK, Kasper GK. Statewide study of chloramphenicol therapy and fatal aplastic anemia. JAMA 1969;208:2045-50.","journal-title":"JAMA"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/clinids\/10.5.1048","article-title":"Aplastic anemia associated with parenteral chloramphenicol: review of 10 cases, including the second case of possible increased risk with cimetidine","volume":"10","author":"West, B.C.; DeVault, G.A.; Clement, J.C.; Williams, D.M.","year":"1988","unstructured":"West BC, DeVault GA, Clement JC, Williams DM. Aplastic anemia associated with parenteral chloramphenicol: review of 10 cases, including the second case of possible increased risk with cimetidine. Rev Infect Dis 1988; 10: 1048-51.","journal-title":"Rev Infect Dis"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/jac\/22.Supplement_C.167","article-title":"Overview of postmarketing experience with ofloxacin in Germany","volume":"C):","author":"Jungst, G.; Mohr, R.","year":"1988","unstructured":"Jungst G, Mohr R. Overview of postmarketing experience with ofloxacin in Germany. Antimicrob Chemother 1988; 22 (suppl C): 167-75.","journal-title":"Antimicrob Chemother"},{"issue":"1","key":"ref_31","first-page":"144","article-title":"Side effects of ofloxacin in clinical trials and in postmarketing surveillance","volume":"34","author":"Junst, G.; Mohr, R.","year":"1987","unstructured":"Junst G, Mohr R. Side effects of ofloxacin in clinical trials and in postmarketing surveillance. Drugs 1987; 34 (suppl I 1): 144-9.","journal-title":"Drugs"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1128\/AAC.29.2.325","article-title":"In vitro comparison of A-56619, A-56620, amifloxacin, ciprofloxacin, enoxacin, and ofloxacin against methicillin-resistant Staphylococcus aureus","volume":"29","author":"Smith, S.M.","year":"1986","unstructured":"Smith SM. In vitro comparison of A-56619, A-56620, amifloxacin, ciprofloxacin, enoxacin, and ofloxacin against methicillin-resistant Staphylococcus aureus. Antinicrob Agents Chemother 1986; 29: 325-6.","journal-title":"Antinicrob Agents Chemother"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/jac\/16.5.563","article-title":"In-vitro activity of ofloxacin, a quinolone carboxylic acid compared to other quinolones and other microbial agents","volume":"16","author":"Kumada, T.; Neu, H.C.","year":"1985","unstructured":"Kumada T, Neu HC. In-vitro activity of ofloxacin, a quinolone carboxylic acid compared to other quinolones and other microbial agents. Antimicrob Chemother 1985; 16: 563-74.","journal-title":"Antimicrob Chemother"},{"key":"ref_34","first-page":"259","article-title":"The comparative activity of twelve 4-quinolone antimicrobials against Haemophilus influenzae and Streptococcus pneumatiae","volume":"11","author":"Ridgway, G.L.; O'Hare, M.D.; Felmingham, D.; Gruneberg, R.N.","year":"1985","unstructured":"Ridgway GL, O'Hare MD, Felmingham D, Gruneberg RN. The comparative activity of twelve 4-quinolone antimicrobials against Haemophilus influenzae and Streptococcus pneumatiae. DrugsExpRes 1985; 11: 259-62.","journal-title":"DrugsExpRes"},{"issue":"79","key":"ref_35","first-page":"1129","article-title":"Chloramphenicol: what we have learned in the last decade","volume":"1986","author":"Feder, H.M.","unstructured":"Feder HM. Chloramphenicol: what we have learned in the last decade. South Med]7 1986: 79: 1129-34.","journal-title":"South Med]7"},{"key":"ref_36","first-page":"287","article-title":"Systemic reactions to ophthalmic drug preparations. Med Toxicol Adverse Drug Exp","volume":"2","author":"Fraunfelder, F.T.; Meyer, S.M.","year":"1987","unstructured":"Fraunfelder FT, Meyer SM. Systemic reactions to ophthalmic drug preparations. Med Toxicol Adverse Drug Exp 1987; 2: 287-93."}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjo.75.11.675","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T10:18:10Z","timestamp":1601115490000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjo.75.11.675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,11,1]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1991,11,1]]}},"URL":"https:\/\/doi.org\/10.1136\/bjo.75.11.675","relation":{},"ISSN":["0007-1161"],"issn-type":[{"value":"0007-1161","type":"print"}],"subject":[],"published":{"date-parts":[[1991,11,1]]}}}